Is this the beginning of the end of rheumatic heart disease?
The George Institute for Global Health
Level 5, 1 King Street, Newtown
Join us at the latest #GeorgeTalks for a special talk on a program of work to end rheumatic heart disease.
Nearly 5000 Aboriginal and Torres Strait Islander people are living with the effects of rheumatic heart disease (RHD). Without action, more than 10,000 people will develop the disease by 2031. On average, First Nations people with RHD die at 41 years of age. Rheumatic heart disease, and the suffering it causes, is preventable.
Both major political parties have committed to end rheumatic heart disease. Dr Rosemary Wyber from the END Rheumatic Heart Disease Centre of Research Excellence based at Telethon Kids Institute will discuss how this can be achieved, what it will cost and how tackling rheumatic heart disease can contribute to closing the gap in Aboriginal and Torres Strait Islander peoples health outcomes. Join us to learn more about the role of Aboriginal and Torres Strait Islander peak bodies, community-level action and government engagement underway to bring the end of RHD to fruition.
Dr Rosemary Wyber is a PhD Candidate, Office of the Chief Scientist, The George Institute for Global Health.
She is a General Practitioner who completed her Masters of Public Health at the Harvard School of Public Health and her General Practice training in Aboriginal Community Controlled Clinics in the Northern Territory of Australia. Rosemary’s primary research interest is rheumatic heart disease in Indigenous and resource-limited communities worldwide. Her PhD at The George Institute for Global Health focuses on policy decisions related to RHD in Australia. Rosemary is also Senior Adjunct Research Fellow at the University of Western Australia and the Head of Strategy for END RHD.